Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to All Reviews
Investigation Report
TOM Weight Loss Tirzepatide Review
TOM Weight Loss, Texas Obesity Medicine, tomweightloss.com
Also spelled as TOM Weight Loss, Texas Obesity Medicine, tomweightloss.com — Same brand, same great service!
Our investigation of Compounded Tirzepatide from TOM Weight Loss
Under Watch
Some concerns noted, proceed with caution
7.6/10
Good OptionRank#178 of 226
Visit TOM Weight LossPrescription treatment requires clinician review
Under Watch
Tirzepatide from $249/month; à la carte from $100/month; $50/month medication route for eligible Medicare members
100+
Hours Researched
8
Verified Pros
8
Issues Found
7.6
Final Score
These are Med Consumer Watch products, not products from TOM Weight Loss, the brand being reviewed on this page.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Investigation Overview
TOM Weight Loss is a small telehealth practice with an unusually credible clinical footing and published prices. Our research (August 8, 2026) found board-certified obesity medicine delivered in two states.
Board-Certified Obesity Medicine
The practice describes itself as "telehealth obesity medicine" serving Texas and Utah, with each patient assigned "your own board-certified doctor." Obesity medicine is a recognised subspecialty with its own board certification, and it is not a credential most operators in this comparison claim. A physician board-certified in obesity medicine is trained specifically in the condition these drugs treat — as opposed to a general telehealth clinician adding weight loss to a service menu.Published Pricing
- Tirzepatide from $249/month
- À la carte now $100/month
- Compounded semaglutide at any dose up to 2.4 mg per week
- Injectable and oral options in both molecules
The Medicare Route
"$50/month weight-loss medication for Medicare members: see if you qualify"This corresponds to the Medicare GLP-1 Bridge we documented at LillyDirect, under which eligible Medicare Part D patients may obtain Zepbound for no more than $50/month subject to clinical criteria. A practice that surfaces this route rather than steering Medicare patients into cash-pay compounded medication is acting in the patient's interest — the approved product at $50 beats a compounded copy at $249 on both price and quality.
How It Positions Itself
"Medical weight loss online for Texas and Utah: your own board-certified doctor, a plan built around your body and your goals, and your medication delivered to your door. All included. No insurance, no waiting rooms, no being treated like a number." Also: 24/7 support and cancel anytime.Limitations
Two states only — Texas and Utah. Compounded medication for the main programs, with no named pharmacy and no stated 503A or 503B status. The two price points need clarifying. "Tirzepatide from $249/mo" and "à la carte now $100/mo" describe different things, and the site does not make the distinction obvious — establish which applies to you. Oral options appear in the medication filter alongside injectables. Unless these are the FDA-approved oral products, compounded oral GLP-1s carry the absorption problem we have documented throughout. No published BMI or eligibility criteria, lab requirements or monitoring schedule.Our Investigation Summary
Our research (August 8, 2026) found TOM Weight Loss operating a telehealth obesity medicine practice serving Texas and Utah, with each patient assigned a board-certified doctor — obesity medicine being a recognised subspecialty with its own board certification, and a credential few operators in this comparison claim. Pricing is published: tirzepatide from $249/month, an à la carte option at $100/month, and compounded semaglutide at any dose up to 2.4 mg weekly with everything included in one price. The dosing detail matters, since titrating to the full 2.4 mg used in the STEP trials avoids the financial disincentive created by programs that price by dose and effectively encourage patients to stall below therapeutic levels. The practice also surfaces a $50/month medication route for eligible Medicare members, corresponding to the Medicare GLP-1 Bridge under which eligible Part D patients may obtain Zepbound for no more than $50 subject to clinical criteria — a practice that directs Medicare patients toward the approved product at $50 rather than compounded medication at $249 is acting in the patient's interest on both price and quality. Support is 24/7 with cancel-anytime terms and no insurance required. Limitations: service is restricted to Texas and Utah; the main programs use compounded medication with no named pharmacy and no stated 503A or 503B status; the relationship between the "$249/mo" and "$100/mo à la carte" figures is not made clear; oral options appear alongside injectables and, unless they are the FDA-approved products, carry the absorption problems documented throughout this comparison; and no BMI or eligibility criteria, lab requirements or monitoring schedule is published.
How TOM Weight Loss Works
1
Start your consultation online — service covers Texas and Utah
2
You are assigned your own board-certified obesity medicine doctor
3
Your doctor builds a plan around your body, history and goals
4
Medication is delivered to your door with everything included in the price
5
Compounded semaglutide is available at any dose up to 2.4 mg per week
6
Medicare members should ask about the $50/month medication route before enrolling
7
24/7 support is included and you can cancel at any time
What We Found
What's Good
- Board-certified obesity medicine doctors — a recognised subspecialty credential
- Each patient assigned their own doctor rather than a rotating pool
- Published pricing: tirzepatide from $249/month, à la carte from $100/month
- Titrates compounded semaglutide to any dose up to the full 2.4 mg weekly trial dose
- Surfaces the $50/month Medicare medication route rather than steering Medicare patients to cash-pay
- All-inclusive pricing with medication delivered to your door
- 24/7 support and cancel anytime with no contract
- Both injectable and oral options offered
Watch Out For
- Available only in Texas and Utah
- Main programs use compounded medication with no named pharmacy
- 503A/503B status not disclosed
- The relationship between the $249/month and $100/month à la carte prices is unclear
- Oral options carry absorption uncertainty unless they are FDA-approved products
- No published BMI thresholds or eligibility criteria
- No published lab requirements or monitoring schedule
- Compounded medications are not FDA-approved for safety, effectiveness or quality
Pricing Breakdown
Starting Price
Tirzepatide from $249/month; an à la carte option is advertised at $100/month
Medication Cost
Included. Compounded semaglutide at any dose up to 2.4 mg weekly, and tirzepatide from $249/month, with injectable and oral options
Subscription Fees
All-inclusive pricing with no insurance required. Cancel anytime
Hidden Fees
None identified. Eligible Medicare members are directed to a $50/month medication route, which is cheaper than the cash-pay programs
Safety & Medical Oversight
TOM Weight Loss assigns each patient a board-certified doctor and describes itself as a telehealth obesity medicine practice. Obesity medicine board certification is a recognised subspecialty credential specific to the condition these medications treat, and it is a meaningfully higher qualification claim than the generic "licensed provider" language most operators in this comparison use. The practice states it prescribes compounded semaglutide at any dose up to 2.4 mg per week, which corresponds to the full therapeutic dose used in the STEP trials — important because programs that price by dose create a financial disincentive for patients to titrate to levels that produced the published results. It also directs eligible Medicare members toward a $50/month medication route, which corresponds to the Medicare GLP-1 Bridge for FDA-approved Zepbound; steering Medicare patients toward approved product rather than compounded medication is both cheaper and clinically preferable. Areas requiring caution: the main programs dispense compounded medication, and the practice does not name its compounding pharmacy or state whether it operates under 503A or 503B, so patients cannot assess the regulatory framework, testing or accreditation behind their vial. Oral options appear in the medication range; unless these are the FDA-approved oral products, compounded oral and sublingual GLP-1 preparations have no published evidence establishing what dose reaches the bloodstream. No BMI or clinical eligibility thresholds, laboratory requirements, or ongoing monitoring schedule is published. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Customer Support
TOM Weight Loss provides 24/7 support with cancel-anytime terms and no contract, and assigns each patient their own board-certified doctor rather than routing them through a rotating clinician pool — a continuity advantage that matters for dose titration and side-effect management. Medication is delivered to the door with everything included in the stated price, and no insurance is required. The practice frames its offering explicitly against the impersonal alternative: "no insurance, no waiting rooms, no being treated like a number." Service is limited to Texas and Utah. We found no published support hours detail beyond the 24/7 claim, no response-time commitments, and no refund terms.
Key Features
Board-Certified Obesity Medicine
Texas and Utah
Tirzepatide From $249/Month
Semaglutide to Full 2.4 mg Dose
$50/Month Medicare Route Surfaced
All-Inclusive Pricing
24/7 Support, Cancel Anytime
Injectable and Oral Options
Best For
Texas and Utah patients who want a board-certified obesity medicine physician rather than a general telehealth clinician — and Medicare members who should ask about the $50 route first
Customer Reviews & Complaints
We assessed TOM Weight Loss against its published material as of August 8, 2026.
What we verified directly: telehealth obesity medicine serving Texas and Utah; each patient assigned a board-certified doctor; compounded semaglutide at any dose up to 2.4 mg weekly; tirzepatide from $249/month; an à la carte option at $100/month; injectable and oral options for both molecules; a $50/month medication route advertised for eligible Medicare members; all-inclusive pricing; 24/7 support; and cancel-anytime terms with no insurance required.
The obesity medicine credential is the finding. It is a recognised subspecialty, and very few operators in this comparison claim it. A physician trained specifically in obesity is a different proposition from a general clinician reviewing a weight-loss questionnaire.
The Medicare disclosure is the second. A cash-pay practice surfacing a $50 route that competes with its own $249 program is pointing patients somewhere better for them and worse for itself. That is unusual and worth crediting.
What needs clarifying before you enrol is the two price points. "$249/mo" and "à la carte now $100/mo" describe different arrangements, and the distinction was not clear from the material we reviewed.
What we could not establish: the compounding pharmacy and its regulatory pathway, what the à la carte price covers, whether oral options are FDA-approved or compounded, eligibility criteria, lab requirements, monitoring schedules, founding year, refund terms, or independent third-party review aggregates.
Is TOM Weight Loss Legit?
"Is TOM Weight Loss legitimate?" Our assessment as of August 8, 2026.
Official Verification: The practice describes board-certified obesity medicine physicians serving two named states with published pricing and all-inclusive terms. Board certification is independently verifiable once you have your physician's name. We found no evidence of wrongdoing.
The clinical credential is the strongest signal here. Obesity medicine board certification requires specific training and examination in the condition, and it is the qualification you would want in whoever decides your dose, manages your side effects and judges whether you should be on these drugs at all.
Two practices stand out as patient-first. Titrating to the full 2.4 mg rather than capping below it means patients can actually reach the dose that produced the trial results. And surfacing a $50 Medicare route that undercuts its own program is the kind of disclosure that costs the company money.
The unresolved question is the pharmacy. Compounded medication with no named pharmacy and no stated pathway is the most common gap in this whole comparison, and it applies here too. Ask before enrolling — and if you are Medicare-eligible, price the $50 approved-product route first.
Red Flags Check:
- ✓ Board-certified obesity medicine physicians
- ✓ Dedicated doctor per patient, not a rotating pool
- ✓ Pricing published for main programs
- ✓ Titrates to the full 2.4 mg weekly trial dose
- ✓ Surfaces a cheaper Medicare route that competes with its own product
- ✓ 24/7 support, cancel anytime, no contract
- ⚠ Texas and Utah only
- ⚠ Compounding pharmacy not named; 503A/503B status undisclosed
- ⚠ Two price points not clearly distinguished
- ⚠ Oral options may carry absorption uncertainty
- ⚠ No eligibility criteria, lab requirements or monitoring schedule
The Bottom Line: If you are in Texas or Utah, a board-certified obesity medicine physician managing your treatment is a genuine step up from the general-telehealth tier. Ask which pharmacy compounds your medication, what the à la carte price actually covers, and — if you are on Medicare — start with the $50 route they themselves point to. As always, consult your personal physician before starting any new medication program.
Our Verdict: Under Watch
TOM Weight Loss has a 7.6/10 site score. While this provider meets basic standards, there are some areas for improvement. Consider comparing with our top-rated options before making a decision.
Visit TOM Weight LossTOM Weight Loss
Under Watch
7.6/10
Tirzepatide from $249/month; à la carte from $100/month; $50/month medication route for eligible Medicare members
Prescription treatment requires clinician review
Investigation Summary
Overall Rank#178 of 226
Rating7.6/10
StatusUnder Watch
PricingTirzepatide from $249/month; à la carte from $100/month; $50/month medication route for eligible Medicare members
Share Your Experience
Help others by sharing your experience with TOM Weight Loss
Want to compare options?
View All 226 ProvidersUser Reviews
Rating Summary
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
226 Providers Reviewed
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Promotional placement: CoreAge Rx is featured #1 and SuperHealthy Rx #2. Placements and site scores are not independent clinical ratings or patient review averages. We may earn compensation from referral links. How our rankings work.
#1 RecommendedExcellent
#2 RecommendedExcellent
#3 RecommendedGreat
Mochi Health
8.8
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
More Provider Reviews
CoreAge Rx
9.9
SuperHealthy Rx
9.7
Mochi Health
8.8
Remedy Meds
8.3
Under Watch
Ready to Get Started with TOM Weight Loss?
Review our findings above and make an informed decision about TOM Weight Loss.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.